Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Giovanna Del Principe"'
Autor:
Beatrice Marziani, Valentina Pecora, Giovanna Leone, Giorgia Bracaglia, Giovanna Del Principe, Stefania Arasi, Veronica Calandrelli, Paola Zangari, Alessandro Fiocchi
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100417- (2020)
Externí odkaz:
https://doaj.org/article/53fa894065104d93bda5f21580a9a377
Autor:
Pietro Merli, Mattia Algeri, Federica Galaverna, Francesco Quagliarella, Valentina Bertaina, Elia Girolami, Antonella Meschini, Giovanna Del Principe, Simone Biagini, Raffaella Sborgia, Barbarella Lucarelli, Daria Pagliara, Marialuigia Catanoso, Chiara Rosignoli, Matilde Cossutta, Francesca Lanzaro, Costanza Canino, Maria Giuseppina Cefalo, Luisa Strocchio, Emilia Boccieri, Marco Becilli, Roberto Carta, Francesca Del Bufalo, Giuseppina Li Pira, Franco Locatelli
Publikováno v:
Blood. 140:1879-1881
Autor:
Daria Pagliara, Stefania Gaspari, Luisa Strocchio, Francesco Quagliarella, Matteo Di Nardo, Marco Becilli, Francesca Del Bufalo, Mattia Algeri, Giovanna Del Principe, Valentina Bertaina, Giuseppina Li Pira, Olivia Marini, Tiziana Corsetti, Emilia Boccieri, Federica Galaverna, Antonio Giacomo Grasso, Pietro Merli, Franco Locatelli
Publikováno v:
Blood. 136:2-4
Background: allogeneic HSCT is the only potentially curative treatment for many non-malignant diseases (NMD), either inherited or acquired. However, many patients lack an HLA-matched donor (familiar (MFD) or unrelated (MUD)) and the outcome of childr
Autor:
Giovanna Leone, Giorgia Bracaglia, Alessandro Fiocchi, Beatrice Marziani, Stefania Arasi, Giovanna Del Principe, Veronica Calandrelli, Valentina Pecora, Paola Zangari
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100417-(2020)
Autor:
Sergio Rutella, Franco Locatelli, Katia Girardi, Giovanna Del Principe, Fabiola Landi, Stefano Ceccarelli, Giuseppina Li Pira, Alice Bertaina, Rita Maria Pinto, Perla Filippini, Daria Pagliara, Paola Giustiniani
Publikováno v:
Blood. 120:343-343
Abstract 343 Introduction. Allogeneic hematopoietic stem cell transplantation (HSCT) from a HLA-haploidentical relative is a suitable option for patients (pts) lacking a compatible donor, either related or unrelated. The two main approaches for overc